App aims to boost ozempic adherence in diabetes patients

NCT ID NCT06478550

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested whether a smartphone app helps people with type 2 diabetes stick with their weekly Ozempic injections. 304 participants either used the app or received standard care. The study tracked how long they stayed on the medication and if they reached their target dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • "Laiko" General Hospital of Athens

    Goudi/Athens, 11527, Greece

  • General Hospital Of Thessaloniki Papageorgiou

    Thessaloniki, Nea Efkarpia, 56429, Greece

  • General Hospital of Thessaloniki 'G. Gennimatas

    Thessaloniki, 54635, Greece

  • Geniko Nosokomeio Peiraia Tzaneio

    Piraeus, 18536, Greece

  • Univ Gen Hospital Larisa

    Larissa, 41110, Greece

  • University Hospital of Athens ATTIKON

    Athens, Attica, 12462, Greece